MedWatch

Novo Nordisk chair foresees pressure on pharmaceutical industry

Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.

Photo: Novo Nordisk Pharmatech/PR

Novo Nordisk's Chair of the Board Helge Lund predicts that Danish tax payers will, to a large extent, be paying the bills for the coronavirus crisis in this country, but that the pharmaceutical industry will also be put under pressure, according to Danish media Finans.

"We can only expect that there'll be more pressure on the pharmaceutical industry in future years," Lund tells Finans.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs